đź“šExpertise
Evidence Synthesis
I leverage a suite of evidence synthesis methods, including systematic review, meta-analysis, network-meta analysis, and umbrella review to answer complex health questions when data from a single study is insufficient.
My expertise in this area allows me to build a comprehensive understanding of a topic, identify critical gaps in the literature, and provide a robust foundation for health policy decisions.
Research Projects:
Health Equity in COVID-19 in the United States
This project was a central component of my doctoral research at the University of Utah. As a member of the research team for the CDC-funded ShePheRD project, I was responsible for two key evidence synthesis components.
- A scoping review to map the existing evidence on social determinants of health within COVID-19 transmission models.
- An umbrella review to consolidate and evaluate high-level evidence on racial and ethnic disparities in health outcomes.
Selected papers
Duong KNC, Nguyen DT, Kategeaw W, Liang X, Visnovsky LD, Veettill SK, McFarland MM, Nelson RE, Jones BE, Pavia AT, Coates E, Khader K, Love J, Yon GV, Zhang Y, Willson T, Dorsan E, Toth D, Jones MM, Samore MH, Chaiyakunapruk N. Incorporating social determinants of health into transmission modeling of COVID-19 vaccine in the US: A scoping review. The Lancet Regional Health of Americas. 2024;35:100806. Link
Duong KNC, Le LM, Veettil SK, Saidoung P, Wannaadisai W, Nelson RE, Friedrichs M, Jones BE, Pavia AT, Jones MM, Samore MH, Chaiyakunapruk N. Disparities in COVID-19 related outcomes in the United States by race and ethnicity pre-vaccination era: an umbrella review of meta-analyses. Frontiers in Public Health. 2023;11:1206988. Link
Cost-effectiveness Analysis
To address crucial questions about the economic value of health interventions, I develop and implement cost-effectiveness models. Using techniques like decision trees and Markov models, I estimate both the short-term and long-term impacts of interventions or health policies.
Research Project:
Cost-effectiveness of pharmacogenetics in Vietnam
This project applied a combination of a decision tree and a Markov model to evaluate a key question in pharmacogenomics: whether HLA-B*58:01 screening is a cost-effective strategy for preventing adverse drug reactions in gout patients in Vietnam
Selected papers
Duong KNC, Nguyen DV, Chaiyakunapruk N, Nelson RE, Malone DC. Cost-effectiveness of HLA-B*58:01 testing to prevent Stevens-Johnson syndrome/toxic epidermal necrolysis in Vietnam. Pharmacogenomics. 2023;24(13):713-724. Link
🏆Grants & Funding
2024 – 2025
Forecasting and Surveillance of Infectious Threats and Epidemics (ForeSITE)
- Funding Agency: Center for Forecasting and Outbreak Analytics – Centers for Disease Control and Prevention (CFA – CDC)
- Role: Research Assistant
2021 – 2024
Research to Improve National and Global Responses to Emerging Health Threats: Accelerating the Integration of Novel Data Streams in Mathematical Models (SHEPheRD_RFTOP 2021 -1A-015)
- Funding Agency: Centers for Disease Control and Prevention (CDC)
- Role: Research Assistant
Khanh Duong 